Permanent Hair Loss Associated with Taxane Chemotherapy Use in Breast Cancer: a Retrospective Review at Two Tertiary UK Cancer Centres

Purpose: Permanent chemotherapy-induced alopecia (pCIA) is an increasingly recognised complication of taxane-based chemotherapy that may be associated with significant psychological morbidity [1]. The prevalence of pCIA following docetaxel is poorly understood and there are no published data on paclitaxel chemotherapy. Here we analyse prevalence and patterns of pCIA in patients who received docetaxel or paclitaxel across two UK tertiary cancer centres.

Source: Clinical Oncology - July 8, 2020 Category: Radiology Authors: H. Adderley, J. Chan, M. Alameddine, C. Kelly, Z. Salih, K.H.J. Lim, R. Fox, C. Tetlow, D. Arundell, H. Wong, M. Harries, A. Armstrong, N. Thorp Source Type: research